(Q33454999)

English

Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

reproducibility

1 reference

based on heuristic

inferred from title

0 references

0 references

immunohistochemistry

1 reference

based on heuristic

inferred from title

Samuel Aparicio

9

object named as

Samuel Aparicio

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Gulisa Turashvili

1

object named as

Gulisa Turashvili

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

5

object named as

Blake Gilks

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Samuel Leung

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dmitry Turbin

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kelli Montgomery

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Rob West

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Melinda Carrier

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

David Huntsman

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

29 May 2009

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

165

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Amplification of HER2 is a marker for global genomic instability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

28 July 2018

Current issues in ER and HER2 testing by IHC in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

28 July 2018

''R"--project for statistical computing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

28 July 2018

Comparing subjective and digital image analysis HER2/neu expression scores with conventional and modified FISH scores in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

28 July 2018

Semi-automated imaging system to quantitate Her-2/neu membrane receptor immunoreactivity in human breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

28 July 2018

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

28 July 2018

High inter-observer agreement in immunohistochemical evaluation of HER-2/neu expression in breast cancer: a multicentre GEFPICS study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

28 July 2018

Quantification of immunohistochemistry--issues concerning methods, utility and semiquantitative assessment II.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

28 July 2018

Quantification of immunohistochemistry--issues concerning methods, utility and semiquantitative assessment I.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

28 July 2018

HER-2 status in breast cancer: correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

28 July 2018

Interobserver reproducibility of immunohistochemical HER-2/neu assessment in human breast cancer: an update from INQAT round III.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

28 July 2018

IHC for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest in breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

28 July 2018

HER2 amplification status in breast cancer: a comparison between immunohistochemical staining and fluorescence in situ hybridisation using manual and automated quantitative image analysis scoring techniques

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

28 July 2018

Role of HER2/neu in tumor progression and therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

28 July 2018

The use of cell line standards to reduce HER-2/neu assay variation in multiple European cancer centers and the potential of automated image analysis to provide for more accurate cut points for predicting clinical response to trastuzumab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

28 July 2018

Enhanced accuracy and reliability of HER-2/neu immunohistochemical scoring using digital microscopy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

28 July 2018

Interlaboratory comparison in HercepTest assessment of HER2 protein status in invasive breast carcinoma fixed with various formalin-based fixatives.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

28 July 2018

Color realism and color science

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

28 July 2018

The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

28 July 2018

Interobserver reproducibility of Her-2/neu protein overexpression in invasive breast carcinoma using the DAKO HercepTest

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

28 July 2018

Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

28 July 2018

A testing algorithm for determination of HER2 status in patients with breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

28 July 2018

Update on HER-2 as a target for cancer therapy: intracellular signaling pathways of ErbB2/HER-2 and family members

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

28 July 2018

Concordance in judgments among c-erbB-2 (HER2/neu) overexpression detected by two immunohistochemical tests and gene amplification detected by Southern blot hybridization in breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

28 July 2018

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

28 July 2018

C-erbB-2 immunostaining: problems with interpretation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

28 July 2018

HER2 testing: a review of detection methodologies and their clinical performance

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-165

21 January 2018

Analytical validation and interobserver reproducibility of EnzMet GenePro: a second-generation bright-field metallography assay for concomitant detection of HER2 gene status and protein expression in invasive carcinoma of the breast.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-165

21 January 2018

Detection of HER-2/neu (c-erb B-2) DNA amplification in primary breast carcinoma. Interobserver reproducibility and correlation with immunohistochemical HER-2 overexpression.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-165

21 January 2018

Refinement of immunohistologic parameters for Her2/neu scoring validation by FISH and CISH.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-165

21 January 2018

Time course of chromatic adaptation for color appearance and discrimination.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-165

21 January 2018

Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-165

21 January 2018

Comparison of immunohistochemistry by automated cellular imaging system (ACIS) versus fluorescence in-situ hybridization in the evaluation of HER-2/neu expression in primary breast carcinoma.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-165

21 January 2018

Quantitative immunohistochemical evaluation of HER2/neu expression with HercepTestTM in breast carcinoma by image analysis.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-165

21 January 2018

Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-165

21 January 2018

HER2--a discussion of testing approaches in the USA.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-165

21 January 2018

Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its impl

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-165

21 January 2018

HER-2/neu in breast cancer: interobserver variability and performance of immunohistochemistry with 4 antibodies compared with fluorescent in situ hybridization.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-165

21 January 2018

Which breast carcinomas need HER-2/neu gene study after immunohistochemical analysis? Results of combined use of antibodies against different c-erbB2 protein domains.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-165

21 January 2018

Dysregulation of cellular signaling by HER2 in breast cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-165

21 January 2018

Dysregulation of cellular signaling by HER2/neu in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

31 October 2018

Histological tumor grade correlates with HER2/c-erB-2 status in invasive breast cancer: a comparative analysis between immunohistochemical (CB11 clone and Herceptest), FISH and differential PCR procedures.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

31 October 2018

Immunohistochemical evaluation of HER-2/neu expression in infiltrating breast carcinoma: a study of reproducibility.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2698924

31 October 2018

Selecting Antibodies to Detect HER2 Overexpression by Immunohistochemistry in Invasive Mammary Carcinomas

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-165

21 January 2018

[Reproducibility of Her-2/neu overexpression with HERCEP test in invasive ductal breast cancer]

1 reference

https://pubmed.ncbi.nlm.nih.gov/19476653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interobserver reproducibility of immunohistochemical HER-2/neu evaluation in human breast cancer: the real-world experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/19476653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of immunohistochemical and fluorescence in situ hybridization assessment of HER-2 status in routine practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/19476653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TMA-Combiner, a simple software tool to permit analysis of replicate cores on tissue microarrays

1 reference

https://pubmed.ncbi.nlm.nih.gov/19476653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2 status determination in breast carcinomas. A practical approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/19476653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system

1 reference

https://pubmed.ncbi.nlm.nih.gov/19476653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: apparent immunohistochemical false-positives do not get the message

1 reference

https://pubmed.ncbi.nlm.nih.gov/19476653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new rabbit monoclonal antibody (4B5) for the immunohistochemical (IHC) determination of the HER2 status in breast cancer: comparison with CB11, fluorescence in situ hybridization (FISH), and interlaboratory reproducibility

1 reference

https://pubmed.ncbi.nlm.nih.gov/19476653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New cutpoints to identify increased HER2 copy number: analysis of a large, population-based cohort with long-term follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/19476653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19476653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Laboratory testing for HER2/neu in breast carcinoma: an evolving strategy to predict response to targeted therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19476653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of interobserver agreement in scoring immunohistochemical results of HER-2/neu (c-erbB-2) expression detected by HercepTest, Nichirei polyclonal antibody, CB11 and TAB250 in breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19476653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER2 assessment by immunohistochemical analysis and fluorescence in situ hybridization: comparison of HercepTest and PathVysion commercial assays

1 reference

https://pubmed.ncbi.nlm.nih.gov/19476653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831

1 reference

https://pubmed.ncbi.nlm.nih.gov/19476653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Immunochemistry evaluation of HER2 status in infiltration breast cancer: technical protocol and interpretation guidelines]

1 reference

https://pubmed.ncbi.nlm.nih.gov/19476653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of HER-2/neu immunohistochemical assay sensitivity and scoring on formalin-fixed and paraffin-processed cell lines and breast tumors: a comparative study involving results from laboratories in 21 countries

1 reference

https://pubmed.ncbi.nlm.nih.gov/19476653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Machine scoring of Her2/neu immunohistochemical stains

1 reference

https://pubmed.ncbi.nlm.nih.gov/19476653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French multicentre GEFPICS study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19476653

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-9-165

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-9-165

9 September 2019

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33454999&oldid=2195379647"